HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rodney L Balhorn Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

10/2007Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rodney L Balhorn Research Topics

Disease

2Lymphoma (Lymphomas)
10/2007 - 08/2007
2Leukemia
10/2007 - 08/2007
2Rupture
02/2006 - 04/2004
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2007
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2007

Drug/Important Bio-Agent (IBA)

3LigandsIBA
10/2007 - 04/2004
2AntibodiesIBA
10/2007 - 08/2007
2Radioisotopes (Radionuclides)IBA
10/2007 - 08/2007
2Proteins (Proteins, Gene)FDA Link
02/2006 - 04/2004
2PolymersIBA
02/2006 - 04/2004
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2007
1HLA-DR10 antigenIBA
10/2007
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2007
1HLA-DR Antigens (HLA-DR)IBA
08/2007
1HLA Antigens (Human Leukocyte Antigens)IBA
08/2007
1Concanavalin AIBA
02/2006
1Mannose (D-Mannose)IBA
02/2006
1CarbohydratesIBA
02/2006
1SugarsIBA
04/2004

Therapy/Procedure

2Radiotherapy
10/2007 - 08/2007